Mukka Proteins Stock Evaluation: Buy, Sell, or Hold - Expert Insights:
Mukka Proteins, a company who has specialization in in fish protein products, had launched its IPO with a price band of Rs 26-28 per share. The aims of this IPO was to raise Rs 224 crore . Mukka Proteins is a manufactures of fish meal, fish oil, and fish soluble paste used in aqua feed, poultry feed, and pet food production.
Company has strong market position, diversified product
portfolio, and global presence as key drivers for its revenue growth potential.
Mukka Proteins operates six
production facilities strategically located near coastal areas to ensure
operational efficiency.
Mukka Proteins has demonstrated a
significant revenue growth rate over the years, indicating a positive
trajectory for the company's financial performance. This growth, coupled with
its market position and product offerings, suggests a promising outlook for
Mukka Proteins in the fish protein industry. Mukka Proteins presents a
compelling investment opportunity in the fish protein industry with positive
growth prospects and strong financial performance.
What is the Revenues growth
potential & Financial Performance of Mukka proteins?
The growth potential of Mukka Proteins appears promising
based on its financial performance and market position:
Revenue Growth of
Mukka Proteins:
Mukka Proteins has shown consistent revenue growth over the
years, with a significant increase in value and volume terms. The company aims
to enhance its market share by expanding its product offerings
Profitability of Mukka Proteins:
Despite fluctuating profitability, Mukka Proteins reported a
net profit of Rs 32.98 crore for the period ending September 30, 2023,
indicating a positive trend in earnings.
Market Position of Mukka proteins:
Company has strong foothold in the fish protein industry, diversified product portfolio, and global presence in over 10 countries, Mukka Proteins holds around 25-30% market share in India.
The revenue growth rate of Mukka Proteins has been
impressive, showcasing a positive trend in its financial performance:
FY21-23 Growth of
Mukka Proteins:
Mukka Proteins experienced a robust revenue growth rate of
40% annually between FY21-23.
FY22-23 financial Performance of Mukka Proteins:
Based on Past Financial Performances, In the financial year 2022-23, the company reported a revenue of Rs 1,183.80 crore, marking a substantial increase from the previous year. The company's revenue from operations rose by 53% year-on-year. Company had reported a net profit of Rs 32.98 crore for the period ending September 30, 2023, and revenue of Rs 612.88 crore.
Mukka Proteins Stock Forecast: Buy, Sell, or Hold - What's the Best Move?
Mukka Proteins can be a very good bet for long-term
investment due to its growth potential, innovative products like insect meal
and oil, and strategic market positioning
In conclusion, Mukka Proteins presents a compelling investment opportunity with positive growth prospects driven by its industry expertise, product innovation, and expanding market presence. Companies like Mukka proteins having unique business model, always be appreciated by Stock market investors and traders. So it will not be surprise if Mukka Proteins stock will give very good returns in the long term.
What will be the long
term price targets of “Mukka Proteins” stock?
As we have discussed above the business model, financial performance & Demand of the products of Mukka Proteins, which is looking promising for the future prospectus too. We are Expecting 42rs to 50rs Price Targets in “mukka Proteins” in the coming months. We can upgrade or Downgrade the Mukka proteins stock price targets in the coming months after analyzing its financial performances because we have seen many times, Small companies shows good financials of the companies before IPO but could not sustain those performances after IPO listing which is still a question to SEBI.
Should you buy Mukka
Proteins stock after IPO Listing?
Yes, you can buy Mukka Proteins stock even after IPO Listing if you have long term prospectus but you have to track the financial performance of the company in every quarter because investment in such kind of companies, sometimes can be very risky. So Mukka proteins stock comes under “high risk & High returns” category.
Please do not enter any spam link in the comment box.